GDC-6036-NH

• CAT Number: I043427
• CAS Number: 2417918-80-8
• Molecular Formula: C26H30ClF4N7O
• Molecular Weight: 568.01
• Purity: ≥95%
• Synonyms: 6-[6-chloro-8-fluoro-4-[(2S)-2-methylpiperazin-1-yl]-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-7-yl]-4-methyl-5-(trifluoromethyl)pyridin-2-amine
• InChI: InChI=1S/C26H30ClF4N7O/c1-13-9-18(32)34-23(20(13)26(29,30)31)19-17(27)10-16-22(21(19)28)35-25(39-12-15-5-4-7-37(15)3)36-24(16)38-8-6-33-11-14(38)2/h9-10,14-15,33H,4-8,11-12H2,1-3H3,(H2,32,34)/t14-,15-/m0/s1
• InChIKey: XPOSONRWHCKUDU-GJZGRUSLSA-N
• SMILES: C[C@H]1CNCCN1C2=NC(=NC3=C(C(=C(C=C32)Cl)C4=C(C(=CC(=N4)N)C)C(F)(F)F)F)OC[C@@H]5CCCN5C

GDC-6036-NH（Cat No.:I043427）is an investigational small molecule inhibitor under research for its potential in treating cancer. It specifically targets and inhibits the action of a key enzyme or receptor involved in tumor growth and survival, potentially modulating key signaling pathways critical for cancer cell proliferation and resistance to treatment. By interfering with these pathways, GDC-6036-NH aims to slow or stop cancer progression. The compound is currently undergoing preclinical or early-phase clinical trials to assess its safety, efficacy, and therapeutic potential in various malignancies, particularly those with specific molecular targets.